Reply to the letter to the editor 'new life for retrospective study in the precision oncology era' by Orlandi et al.
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan filippo.pietrantonio@istitutotumori.mi.it.
F
F
Pietrantonio
Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
C
C
Cremolini
D014408:Biomarkers, Tumor / Q000235:genetics*; D003062:Codon / Q000235:genetics*; D015179:Colorectal Neoplasms / Q000235:genetics*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics*; D008297:Male; D009154:Mutation / Q000235:genetics*; D010534:Peritoneal Neoplasms / Q000235:genetics*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*
D014408:Biomarkers, Tumor; D003062:Codon; D048493:Proto-Oncogene Proteins B-raf